Navigation Links
Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Date:11/9/2010

ATLANTA, Nov. 9, 2010 /PRNewswire/ -- UCB (EURONEXT: UCB) and U.S. based partner Immunomedics Inc. (Nasdaq: IMMU) announced that results from the phase IIb study, EMBLEM™, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant* reduction in disease activity in adult patients with moderate to severe active SLE.

The EMBLEM™ study was designed to evaluate the efficacy and safety of epratuzumab (in combination with immunosuppressants) in SLE, identify an optimal dose and regimen for further studies, and validate and analyse the performance of a new composite efficacy endpoint.

The data, which were presented today in Atlanta at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR), demonstrated that, in EMBLEM™, all epratuzumab doses, which ranged from 200mg to 3600mg cumulative dose administered during one 12-week treatment cycle, had numerically superior response rates compared to placebo at week 12. For patients receiving epratuzumab at a cumulative dose of 2400mg, there were meaningful and statistically significant reductions in SLE disease activity, with responder rates more than double those of placebo.

Epratuzumab was associated with a similar incidence of serious adverse events (including infections) and infusion reactions compared to placebo.

"While medical advances have improved the lives and survival of people with lupus, effective therapeutic options remain limited. Given these positive results, we remain excited at the future potential of epratuzumab," commented lead study investigator Daniel J. Wallace, M.D., Clinical Professor of Medicine, David Geffen School of Medicine, UCLA.

Additionally, based on analysis of improvement in BILAG 2004 by body system in EMBLEM™, most patients had symptom reduction or absence of active disease within spec
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 2014 Reportbuyer.com has added a new ... Lasers and Energy Devices Market Outlook to 2020, ... Brazil Aesthetic Lasers and Energy Devices Market ... GlobalData,s new report, "Brazil Aesthetic Lasers and ... market data on the Brazil Aesthetic Lasers and ...
(Date:9/1/2014)... YORK , Sept. 1, 2014 ... market research report is available in its catalogue: ... 2014 - 2024 http://www.reportlinker.com/p02280919/Antibody-Drug-Conjugates-Market-2nd-Edition-2014---2024.html ... (ADCs) are a new class of therapeutic agents, ... pharmaceutical companies. Generally addressed as the marriage of ...
(Date:9/1/2014)... Reportlinker.com announces that a new market ... Drug Discovery Technologies - A Global Market Overview ... The development of new drugs for treating ... in addition to consuming a lot of time. ... involves the utilizing high-throughput screening of large chemical ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 2Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 3Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 4Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 5Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 6Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 7Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 8Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 10Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 11Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 12Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 13Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 14Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 15Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 16Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 17Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 18Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11
... YORK, Dec. 8, 2010 Reportlinker.com announces that ... its catalogue: Global Generic Pharmaceuticals ... The Global Generic Pharmaceuticals Industry Report ... evaluation of the Global Generic Pharmaceuticals Industry Report. ...
... Ill., Dec. 8, 2010 Life Spine announced today ... the OCTAVE Posterior Fusion System, which is intended for ... achieving fusion in conjunction with bone graft. The U.S. ... to the OCTAVE System last month. ...
Cached Medicine Technology:Reportlinker Adds Global Generic Pharmaceuticals Industry Report 2Reportlinker Adds Global Generic Pharmaceuticals Industry Report 3Reportlinker Adds Global Generic Pharmaceuticals Industry Report 4Reportlinker Adds Global Generic Pharmaceuticals Industry Report 5Reportlinker Adds Global Generic Pharmaceuticals Industry Report 6Reportlinker Adds Global Generic Pharmaceuticals Industry Report 7
(Date:9/1/2014)... drilled, fitted with a hand pump, and a community ... time? Half of them break down in a year. ... training, these wells would be rendered unusable; however, a ... (UNC) Water Institute and Water and Sanitation for Africa, ... communities collect fees for repairs and train community members ...
(Date:9/1/2014)... cannabis commonly known as marijuana is ... Massachusetts General Hospital (MGH) investigators found that 40 ... substance use disorder reported experiencing symptoms of withdrawal, ... Study participants reporting withdrawal were more likely ... for mood disorders, although the presence or absence ...
(Date:9/1/2014)... a professional company of women’s dresses and related accessories, ... evening dresses . In addition, the company is now ... All customers can enjoy a big discount, up to ... is one of the leading suppliers in the global ... to create more trendy items. The company's aim is ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to 2020? provides ... The report provides value, in millions of US dollars, ... within market segments –,     Synthetic Meshes ...     Composite Meshes and Biological Meshes. , Hernia ... of a hernia (a bulging of internal organs or ...
(Date:9/1/2014)... News) -- Having regular family meals may help protect ... a new study suggests. Online abuse can lead ... "One in five adolescents experience cyberbullying," Frank Elgar, ... Policy at McGill University in Montreal, said in a ... and online harassment and abuse are difficult for parents ...
Breaking Medicine News(10 mins):Health News:The key to drilling wells with staying power in the developing world 2Health News:The key to drilling wells with staying power in the developing world 3Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 2Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 3Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2
... discontinuing HIV drug therapy and then restarting it as and ... study. New England Journal of Medicine has published the results ... the treatment is discontinued, the patients face a greater chance ... side effects of the anti retro viral drugs that are ...
... rooms not only increase patient privacy but also ... a// University of Florida study. ,The study ... when compared with open-bay, double-occupancy and combination configurations ... has separate rooms for each infant, while the ...
... fortified with specific micronutrients—zinc, iron, selenium, copper, vitamin ... and acute lower// respiratory illness among children in ... Hopkins Bloomberg School of Public Health and the ... India. The study was published November 28, 2006, ...
... robotically assisted laparoscopic surgeries. A robot can easily ... body. Laparoscopic surgeons at// UT Southwestern Medical Center ... surgeries. , Laparoscopic surgeries, are performed ... incision. This usually results in fewer complications, shorter ...
... Ministry of Health and Family Welfare is procuring a ... 100 beds would// have state of art operation theatre, ... unit and its own power generator. ,This ... and can be transported by road, rail or air ...
... spacer between lumbar vertebrae during a procedure called ... minimally invasive way to treat spinal// stenosis, according ... published by ECRI, an independent nonprofit health services ... devices, drugs, biotechnologies, procedures, and health services. ...
Cached Medicine News:Health News:Interrupted Treatment Dangerous to HIV Management 2Health News:Staffers Benefit from Single-Room Design for Baby Care 2Health News:Fortified Milk Reduces Morbidity in Preschool Children 2Health News:North Texas Surgeons Lead Robotically Assisted Laparoscopic Surgeries. 2Health News:Spacer Insertion May Offer Less Invasive Option for Lumbar Problems 2Health News:Spacer Insertion May Offer Less Invasive Option for Lumbar Problems 3
Designed for simple operation, the Model 515C pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
... for an emergency situation, bedside monitoring or ... / Pulse Oximeter delivers accurate SpO 2 ... handheld monitor now contains Nellcors latest OxiMax ... OxiMax sensors. The NPB-75 monitor also features ...
... N-20PA Handheld Pulse Oximeter is a one-of-a-kind ... construction of the N-20PA has been shock-tested, ... conditions it has even withstood the ... portable for spot check measurements and also ...
Medicine Products: